Accelerate your obesity trial timelines with solutions designed for rapid execution by leveraging our team of seasoned experts and advanced patient recruitment solutions.
Article
An Inflection Point in Obesity R&D
May 23, 2025
Discover the latest advancements in obesity research and development in the article "An Inflection Point in Obesity R&D." This piece explores the rapid growth in obesity clinical trials and the promising pipeline of novel anti-obesity medications that are set to redefine treatment options and improve patient outcomes.
Related solutions
Obesity
Therapeutic & Specialty Expertise
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
Early Phase Clinical Trials
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
eCOA
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
